The nanogels, in combination with rolipram, contributed to the recovery of injured tissue Researchers from the Instituto di Ricerche Farmacologiche Mario Negri IRCCS and Politecnico...
The study aims to improve the representation of ethnic diversity within Parkinson’s research A study led by researchers at Queen Mary University and University College...
Participants who received COMPASS showed a clinically significant improvement after 12 weeks Researchers from King’s College London’s (KCL) Institute of Psychiatry, Psychology and Neuroscience (IoPPN)...
AstraZeneca announced today the successful completion of the acquisition of Icosavax, Inc., a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential vaccines using an...
Cardiac quantitative susceptibility mapping successfully visualised iron deposits in patients Researchers from King’s College London (KCL) have investigated a new technique for diagnosing and evaluating...
NRTX-1001 is being assessed for drug-resistant mesial temporal lobe epilepsy Neurona Therapeutics has announced that it has secured $120m in funding to help advance its...
In Europe, stroke-related brain-bleed deaths are expected to increase by 8.9% by 2050 Researchers from King’s College London (KCL) have predicted that the number of...
CLM-HT01 improved blood pressure and minimised adverse reactions in patients Closed Loop Medicine has shared positive results of its novel drug and proprietary technology software,...
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announced that the...